CI Investments Inc’s Altimmune ALT Stock Holding History

CI Investments Inc’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-68,400	Closed	-$800K	–	1205
2022 Q2	$800K	Buy	+68,400	New	+$422K	﹤0.01%	403

Other funds holding ALT

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CI Investments Inc's ALT Position: Q3 2022 in Review

CI Investments Inc sold out of Altimmune (ALT) in Q3 2022, closing a stake of 68,400 shares — an estimated $800K sold.

CI Investments Inc first reported a position in ALT in Q2 2022 and held it in 1 quarter. The position peaked at $800K in Q2 2022. 122 funds tracked by Wall St. Rank hold ALT as of Q3 2022.

CI Investments Inc reported no remaining Altimmune position as of Q3 2022 after selling out during the quarter.
CI Investments Inc sold 68,400 Altimmune shares in Q3 2022, an estimated $800K.
CI Investments Inc first reported a position in Altimmune in Q2 2022 and held it in 1 quarter.
CI Investments Inc's Altimmune position peaked at $800K in Q2 2022.
122 funds tracked by Wall St. Rank held Altimmune as of Q3 2022.

Based on CI Investments Inc's 13F filing for Q3 2022, filed 14 Nov 2022.